IRIDEX Corp (IRIX, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. IRIDEX Corp designs, manufactures, and markets laser equipment used in the ophthalmologic and aesthetic fields. IRIDEX Corp has a market cap of $68.910 million; its shares were traded at around $5.95 with and P/S ratio of 1.54.
For the last quarter IRIDEX Corp reported a revenue of $10.2 million, compared with the revenue of $12.53 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $41.6 million, a decrease of 9.9% from the previous year. For the last five years IRIDEX Corp had an average revenue growth rate of 4.6% a year.
The reported loss per diluted share was $1.11 for the year, an increase of -3.5% from previous year. The IRIDEX Corp had an operating margin of -30.99%, compared with the operating margin of -5.56% a year before. The 10-year historical median operating margin of IRIDEX Corp is 2.19%. The profitability rank of the company is 5 (out of 10).
At the end of the fiscal year, IRIDEX Corp has the cash and cash equivalents of $21.7 million, compared with $23.7 million in the previous year. The company had no long term debt. The interest coverage to the debt is at a comfortable level of 42.1. IRIDEX Corp has a financial strength rank of 9 (out of 10).
At the current stock price of $5.95, IRIDEX Corp is traded at 11.4% premium to its historical median P/S valuation band of $5.34. The P/S ratio of the stock is 1.54, while the historical median P/S ratio is 1.37. The stock lost 54.78% during the past 12 months.
For the complete 20-year historical financial data of IRIX, click here.
